A biotech researcher conducts an experiment at CRP-Santé in Luxembourg
 CRP-Santé (archives)

A biotech researcher conducts an experiment at CRP-Santé in Luxembourg  CRP-Santé (archives)

Gasperich-based food and drug testing lab Eurofins Scientific (EUFI) has made a major move in the pharmaceutical development business by buying a research unit from industry giant Merck KGaA (MRK).

On Thursday Eurofins said it is acquiring the Discovery and Development Solutions business from Merck Millipore, which is part of the Darmstadt, Germany-based drugs and chemicals firm. The DDS unit provides bioanalytical testing for early stage pharmaceutical research and clinical trials.

The terms of the deal were not disclosed.

The Merck unit reported annual turnover of approximately $35 million, and employs roughly 175 staff at its three facilities in the UK and US. After the transaction, DDS will continue to count the German pharmaceutical firm among its clients, according to Eurofins.

Merck said it was selling the outfit because it was not able to adequately expand its services. “The DDS business has demonstrated a potential for success that Merck Millipore is not in a position to fully support,” company spokesman David Elliott told industry website Outsourcing-Pharma.com on Thursday. “We believe that the potential of DDS can be better realised by a company with a strong pharma service focus.”

Ongoing growth

The Luxembourg firm is keen to continue growing in this field. “The addition of DDS into the Eurofins network reinforces our leading position in the discovery pharmacology market, and expands our large molecules bioanalytical service capability to meet the growing needs of our pharmaceutical and biopharmaceutical clients,” Eurofins CEO Dr. Gilles Martin said in a press statement.

Among other buy-outs in the drugs development space, Eurofins purchased the Danish genomics testing firm AROS Applied Biotechnology last February and US-based Pan Labs, which screens molecules for pharmaceutical firms, in September 2012.

Eurofins has also made half a dozen company acquisitions in food and agricultural safety during the same period.

The company was founded 25 years ago in France and relocated its corporate headquarters to the Grand Duchy in 2012. In November, Eurofins reported revenues of €882.2 million from January to September 2013, “representing growth of 17.5%”. The company said it now employed more than 15,000 staff in more than 190 laboratories in 37 countries around the world.